Treatment of feline mammary fibroadenomatous hyperplasia with aglepristone
dc.contributor.buuauthor | Nak, Deniz | |
dc.contributor.buuauthor | Nak, Yavuz | |
dc.contributor.buuauthor | Seyrek, Kamil İntaş | |
dc.contributor.buuauthor | Kumru, İsmail Hakkı | |
dc.contributor.department | Uludağ Üniversitesi/Veteriner Fakültesi/Doğum ve Ji̇nekoloji̇ Anabi̇li̇m Dalı. | tr_TR |
dc.contributor.researcherid | AAH-7292-2019 | tr_TR |
dc.contributor.researcherid | AAH-5494-2021 | tr_TR |
dc.contributor.scopusid | 9280090000 | tr_TR |
dc.contributor.scopusid | 8615464000 | tr_TR |
dc.contributor.scopusid | 6603409870 | tr_TR |
dc.contributor.scopusid | 16637505700 | tr_TR |
dc.date.accessioned | 2022-09-01T07:58:16Z | |
dc.date.available | 2022-09-01T07:58:16Z | |
dc.date.issued | 2004-12 | |
dc.description.abstract | A case of fibroadenomatous hyperplasia of the mammary gland in a nine-month-old female cat is reported. It was treated with medroxyprogesterone acetate for the suppression of oestrus. Two weeks later. hyperplasia occurred in all mammary glands. The progesterone receptor blocker aglepristone was given sc (10mg/kg) on days 1, 2 and 7. Mammary gland hyperplasia had completely regressed by day 21. | en_US |
dc.identifier.citation | Nak, D. vd. (2004). “Treatment of feline mammary fibroadenomatous hyperplasia with aglepristone”. Australian Veterinary Practitioner, 34(4), 161-162. | en_US |
dc.identifier.endpage | 162 | tr_TR |
dc.identifier.issn | 0310-138X | |
dc.identifier.issue | 4 | tr_TR |
dc.identifier.scopus | 2-s2.0-13444256138 | tr_TR |
dc.identifier.startpage | 161 | tr_TR |
dc.identifier.uri | http://hdl.handle.net/11452/28415 | |
dc.identifier.volume | 34 | tr_TR |
dc.identifier.wos | 000226461600005 | tr_TR |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.wos | SCIE | en_US |
dc.language.iso | en | en_US |
dc.publisher | Australian Small Animal Veterinary Assoc | en_US |
dc.relation.journal | Australian Veterinary Practitioner | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Veterinary sciences | en_US |
dc.subject | Felidae | en_US |
dc.subject | Felis catus | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Breast fibroadenoma | en_US |
dc.subject.emtree | Cat | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Estrus | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Nonhuman | en_US |
dc.subject.emtree | Time series analysis | en_US |
dc.subject.emtree | Treatment outcome | en_US |
dc.subject.emtree | Tumor regression | en_US |
dc.subject.emtree | Aglepristone | en_US |
dc.subject.emtree | Antigestagen | en_US |
dc.subject.emtree | Medroxyprogesterone acetate | en_US |
dc.subject.emtree | Unclassified drug | en_US |
dc.subject.scopus | Breast Tumor; Experimental Mammary Neoplasms; Breast Neoplasms | en_US |
dc.subject.wos | Veterinary sciences | en_US |
dc.title | Treatment of feline mammary fibroadenomatous hyperplasia with aglepristone | en_US |
dc.type | Editorial Material | |
dc.wos.quartile | Q4 | en_US |
Files
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: